Prosiectau (193)
Cardiff University Schools involved in this Project
Ex vivo cultures of fresh human brain tissues for testing the safety and efficacy of gene editing approaches for HD (01.11.2021 - 31.01.2024)
- Dion, Vincent
Extracellular vesicle transport in the circulation - A missing link between adipocytes and accelerated vascular dysfunction (01.01.2015 - 31.12.2017)
Extracellular vesicles as companion diagnostics: An international workshop (01.10.2017 - 31.12.2018)
- Clayton, Aled
External review and recommendations regarding the quality and configuration of medical education and training posts (01.10.2022 - 30.09.2024)
- Browne, Julie
Extension to 517193 (01.04.2023 - 31.03.2025)
- Fraser, Donald
Extension study of XLHED male subjects treated with EDI200 in ECP-002 (09.05.2015 - 09.06.2026)
- Clarke, Angus
Extended Access of Momelotinib for Subjects with Primary Myelofibrosis (PMF) or Post-polycythemia Vera or Post-essential Thrombocythaemia Myelofibrosis (Post-PV/ET MF) (03.09.2018 - 30.09.2020)
- Knapper, Steven
Expression of antimicrobial ribonucleases in patients undergoing peritoneal dialysis (01.04.2018 - 18.02.2021)
- Eberl, Matthias
Exploring the transition from relapsing-remitting to secondary progressive multiple sclerosis to inform the production of content of support programmes for patients and carers, and educational packages for clinicians (01.09.2013 - 30.06.2015)
- Edwards, Adrian
Exploring the social, institutional and cultural influences on information use in consultations between patients and health care practitioners (01.10.2006 - 30.11.2010)
- Edwards, Adrian
Exploring the Relationship Between Antigen-Specific T Cells and the Tumour Microenvironment (01.01.2022 - 31.03.2027)
- Gallimore, Awen
Exploring the proteome of CAG/CTG repeat expansions (01.04.2020 - 30.11.2022)
- Larin, Meghan
Exploring the potential to collect standardised epidemiological data regarding children assessed within the healthcare setting for suspected physical (PA) and sexual abuse (SA) in four European countries (01.02.2017 - 31.03.2017)
- Nurmatov, Ulugbek
Exploring the potential of a mobile phone or tablet "app" to help patients with cancer address their information needs (01.10.2013 - 31.03.2017)
- Wood, Fiona
Exploring the nature of anti-tumour T cell response to design better treatment and screening of patients with colorectal cancer (03.06.2013 - 30.06.2017)
- Godkin, Andrew
Exploring the microbiome in patients with advance biliary tract cancer in a first-line, randomized study of Durvalumab in combination with Cisplatin/Gemcitabine "entitled “ABC-12 (05.12.2022 - 04.06.2026)
- Hurt, Christopher
Exploring the link between Ca2 + signalling and cellular metabolic inbalance in cardiomyocyte dysfunction (01.10.2011 - 30.09.2014)
- George, Christopher
Exploring the immunogenicity of colorectal cancer and its implications for immunotherapy (01.09.2016 - 31.12.2024)
- Godkin, Andrew
Exploring the functional underpinnings of PMS1 in CAG repeat expansion (01.09.2022 - 13.12.2024)
- Dion, Vincent
Exploring the feasibility of an internet-based cognitive behavioural therapy programme as a non-pharmaceutical therapeutic intervention for people diagnosed with primary dystonia (01.02.2019 - 31.12.2021)
- Peall, Kathryn
Exploring the acceptability and feasibility of early surveillance for autoimmune diabetes (ELSA) (01.10.2021 - 30.11.2022)
- Dayan, Colin
Exploring roles of complement in dementia models (01.01.2018 - 30.06.2021)
- Morgan, Paul
Exploring NOX2 as a component of multi-target therapy for acute myeloid leukaemia (14.09.2022 - 13.09.2025)
- Tonks, Alex
Exploring microRNA-mediated regulation of renal macrophage function during kidney injury and fibrosis (01.08.2016 - 31.01.2020)
- Liao, Chia-Te
Exploring manipulation of NKp46 to modify immunopathology in chronic HCV infection (01.09.2014 - 01.08.2018)
- Pembroke, Thomas
Exploring innate-like and adaptive gamma delta T cell paradigms in health and disease (01.03.2021 - 28.02.2026)
- Wang, Eddie
Exploring cognitive training as a non-pharmaceutical intervention for people with Huntington's disease (01.04.2016 - 30.06.2021)
- Rosser, Anne
Exploring and dissociating sedative and analgesic effects of dexmedetomidine using FMRI (01.05.2015 - 30.11.2018)
- Saxena, Neeraj
Exploring a genetically targeted therapeutic approach for adenomatous polyposis syndromes in 3D Organoid cell models (01.07.2019 - 01.05.2023)
- Sampson, Julian
Explore the essential characteristics/components of primary care mental health services (01.02.2011 - 30.04.2011)
Exploration of the peripheral immune system in subjects with new onset T1 Diabetes (Not 1D) (13.07.2016 - 31.03.2020)
- Dayan, Colin
Exploration of inflammatory APOE44 astrocytic phenotypes (01.09.2023 - 29.08.2024)
- Pryce-Roberts, Adele
Exploiting Novel Antiviral Immune Responses (01.11.2023 - 31.10.2029)
- Stanton, Richard
EXPLAIN Initiative (01.09.2022 - 30.09.2023)
- Nollett, Claire
Expertise to lead on the development of innovation and business engagement at Pentre Awel (01.05.2022 - 31.03.2023)
- Coles, Barbara
Expertise for writing a funding proposal in respect of an ERC advance grant (01.06.2016 - 31.10.2016)
- Nurmatov, Ulugbek
Expert investigation of an anaesthetic machine (01.08.2013 - 31.08.2013)
Expert advice on experimental research to Phase 1 Evaluation of Child Poverty (26.01.2023 - 17.02.2023)
- White, James
Expansion of confocal microscopy in Cardiff (01.06.2011 - 31.05.2016)
- George, Christopher
Expanding DPUK genetics and integrating with inflammation/immunity research (12.03.2018 - 30.04.2020)
- Williams, Julie
Expanded CAG/CTG repeat disorders (01.09.2019 - 30.09.2023)
- Dion, Vincent
Exosomes control tumour reactive stroma in prostate cancer (01.05.2010 - 30.06.2011)
- Clayton, Aled
Exosomal heparan sulphate proteoglycans drive disease progression in patients with prostate cancer (01.11.2014 - 30.04.2020)
- Webber, Jason
Excitatory-inhibitory balance in adolescents at high genetic risk of mental disorder: A study of cortical gamma oscillations and GABA concentrations in 22q11.2 deletion syndrome (01.09.2013 - 08.12.2018)
- Doherty, Joanne
Excess Treatment Costs (The CONSCOP 2 study) (01.10.2020 - 29.02.2024)
- Dolwani, Sunil
Excess Treatment Costs SenITA study (01.06.2017 - 31.03.2021)
- Mcnamara, Rachel
Excess Treatment Costs - Prostaglandin F2-alpha in thyroid eye disease: Randomised controlled double blind crossover trial (01.10.2013 - 30.09.2015)
- Dayan, Colin
Excess Treatment Costs PACE (01.01.2015 - 31.03.2018)
- Francis, Nicholas
Excess Treatment Costs - OSTRICH (01.10.2013 - 29.02.2016)
- Francis, Nicholas
Excess Treatment Costs - Feasibility of reduction in right sided bowel cancer through contrast enhanced colonoscopy (CONSCOP) (01.07.2014 - 30.06.2016)
- Dolwani, Sunil
Excess Treatment Costs - CREAM (01.01.2014 - 31.12.2014)
- Francis, Nicholas
Excess Treatment Costs - CREAM (03.09.2012 - 31.12.2015)
- Francis, Nicholas
Excess treatment costs: ADVICE study (01.06.2012 - 31.05.2013)
- Francis, Nicholas
Excess treatment - ANDREA-LD study (01.04.2014 - 30.06.2016)
- Kerr, Michael
Examining the relationship between decision support interventions and outcome measurements: Applying the IPDAS instrument to the results of the cochrane systematic review of decision aids (01.09.2009 - 30.11.2010)
Examining the influence of parents on the physical activity behaviours of children with intellectual disabilities (01.02.2016 - 31.01.2018)
- Kelson, Mark
Examining the effects of four phytocannabinoids (CBD, CBDV, DBDA, THCV (chronic dosing, at a range of doses) on PWS-IC behaviour in a number of tasks (01.07.2015 - 31.03.2018)
- Isles, Anthony
Examining telomere dysfunction, fusion and the escape form crisis in human cells (01.04.2015 - 31.03.2020)
- Baird, Duncan
Examining parental ambivalence to HPV vaccination for pre-teen daughters: Capturing accounts of decision making among parents (01.10.2008 - 01.10.2011)
Examination Systems for Biological Systems (28.11.2022 - 31.03.2023)
- Stanton, Richard
EV-Assay; A liquid biopsy transforming prostate cancer diagnosis (01.11.2023 - 31.10.2024)
- Clayton, Aled
Evaluations of individualised evidence for the ethical prioritisation of preventive screening procedures (01.01.2007 - 30.09.2009)
Evaluation of transglutaminase-4 as a therapeutic target and diagnostic tool in human prostate cancer (01.09.2014 - 31.03.2016)
- Jiang, Wen
Evaluation of the VNRX-5133, VNRX-5119 & VRNX-5363 B-lactamases inhibitors in antimicrobial combinations (01.10.2016 - 15.01.2017)
- Walsh, Timothy
Evaluation of the Solution Focused Brief Therapy (SFBT): A randomised controlled trial. Triple P (25.02.2022 - 31.01.2025)
- Coulman, Elinor
Evaluation of the safety of CEdiranib in the prevention of bowel perforation in platinum-resistant Ovarian Cancer (CEBOC) (30.11.2017 - 31.12.2023)
- Casbard, Angela
Evaluation of the palliative and end of life care of people with dementia in Blaenau Gwent (01.04.2015 - 31.03.2016)
- Noble, Simon
Evaluation of the involvement of toll-like receptors in peritoneal dialysis-associated sterile inflammation and fibrosis and their clinical relevance (01.01.2016 - 01.02.2022)
- Raby, Anne-Catherine
Evaluation of the improving access to palliative care services for minority ethnic communities (01.10.2015 - 30.11.2015)
- Nelson, Annmarie
Evaluation of testing and processing parameters for the GenePOC Carba assay (27.06.2018 - 31.12.2019)
- Walsh, Timothy
Evaluation of TAM receptor kinase inhibitor ONO-AX-280 in acute myeloid leukaemia (AML) (15.10.2014 - 30.11.2016)
- Knapper, Steven
Evaluation of RG6080 with potential lactam partners (15.01.2017 - 30.06.2017)
- Walsh, Timothy
Evaluation of PeRsOnalised PrEhabilitation in acute myeloid Leukaemia (PROPEL) (01.09.2022 - 31.08.2027)
- Knapper, Steven
Evaluation of novel folate receptor α (FRα) binding oligopeptides for targeted gene and drug delivery (01.04.2017 - 31.10.2018)
- Parker, Alan
Evaluation of media for susceptibility testing of N. gonorrhoeae (01.01.2023 - 31.03.2024)
- Spiller, Brad
Evaluation of facemasks (01.02.2010 - 31.05.2010)
- Hall, Judith
Evaluation of epidemiology of cancer in people with diabetes in relation to metabolic risk factor (01.10.2010 - 30.09.2012)
Evaluation of electrostatic precipitation to capture and inactivate viral particles from bioaerosols (01.07.2021 - 01.04.2023)
- Parker, Alan
Evaluation of CT26 and 4T1 tumour and metastases targeting of RAW 264.7 (labelled with [89Zr]oxinate-4 and 89zr-DFO-derritin) using PET (01.08.2017 - 31.07.2019)
- Marshall, Christopher
Evaluation of candidate genomic regions to determine genetic predisposition in populations of Alzheimer's patients (09.08.2010 - 08.08.2012)
- Williams, Julie
Evaluation of ATMOLYTICS health analytics software, ATMOHEALTH prototype (01.07.2017 - 31.03.2020)
- Raisanen, Lawrence
Evaluation of a shared decision making tool (01.10.2015 - 30.04.2019)
- Cohen, Deborah
Evaluation of AdD.3D.A20 - a refined, tumour selective virotherapy (01.04.2017 - 30.09.2021)
- Parker, Alan
Evaluating whether autoreactive T cells promote progression of colorectal cancer (01.10.2014 - 30.09.2018)
- Godkin, Andrew
Evaluating user experiences with out of hours services to identify service improvements for primary care provision (15.03.2007 - 31.12.2008)
Evaluating the role of vascular growth factors on osteonecrosis in children treated for acute lymphoblastic leukaemia and the adverse effects of bone disease on quality of life in long-term survivors (07.03.2011 - 06.03.2013)
- Evans, Bronwen
Evaluating the effects of frequency of resistance, stability and virulence of colistin and tigecycline insusceptible carbapenemase positive enterobacteriaceae (01.01.2013 - 31.12.2013)
- Walsh, Timothy
Evaluating the effectiveness of using a diabetes needs assessment tool to improve knowledge of diabetes (DNAT): A randomised controlled trial (01.01.2009 - 31.10.2009)
- Hood, Kerenza
Evaluating the clinical effectiveness and cost-effectiveness of a policy of freezing all embryos followed by thawed frozen embryo transfer, compared with a policy of fresh embryo transfer in women undergoing in-vitro fertilization (01.05.2018 - 30.04.2019)
- Azzopardi, Duncan
Evaluating novel oncolytic adenovirus in combination with chemotherapy for efficacious cancer therapeutics (01.12.2013 - 30.11.2016)
- Parker, Alan
Evaluating immunovirotherapies in ex vivo ascites-based models of ovarian cancer (01.01.2022 - 31.12.2023)
- Parker, Alan
Evaluating equality in Covid-19 vaccine uptake (01.10.2022 - 31.07.2023)
- Edwards, Adrian
Evaluating effectiveness, safety, patient experience and system implications of different models of using GPs in or alongside emergency departments (01.03.2017 - 31.07.2024)
- Edwards, Adrian
Evaluating a new protocol for primary care-initiated identification and management of patients with familial hypercholesterolaemia: Observational study and cost effectiveness analysis (01.04.2017 - 31.03.2021)
- Paranjothy, Shantini
Evaluate therapeutic questions in acute myeloid leukaemia (01.01.2006 - 01.07.2007)
- Burnett, Alan
Evaluate the implementation of decision support tools (01.07.2010 - 30.06.2011)
-
- Choy, Ernest
Evaluate the daffodil standards (29.03.2022 - 31.03.2024)
- Sivell, Stephanie
Evaluate CMV targets with the aim of producing antibodies of therapeutic value against CMV infection (01.01.2019 - 31.12.2020)
- Stanton, Richard
EUTRIPD (01.12.2011 - 30.11.2015)
- Topley, Nicholas